Deme Karikios

1

Article

0

Comments
  • PhD Candidate, NHMRC Clinical Trials Centre and Clinical Lecturer in Medicine, University of Sydney
Only recently has conversation about access to new drugs been moving to acknowledging the need for a community debate about affordability as well. pixxiestails/Flickr

Why the public should have a say in high‑cost drug subsidies

Sally Wortley, University of Sydney and Deme Karikios, University of Sydney

Decisions about public subsidies for high-cost drugs are naturally quite complex. And while patients have increasingly been given a voice in the process, the views of the wider community have generally…

Contact Deme for

  • General
  • Media request
  • Speaking request
  • Consulting / Advising
  • Research collaboration
  • Research supervision